551 related articles for article (PubMed ID: 32849438)
1. Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection.
Bao L; Zhang C; Dong J; Zhao L; Li Y; Sun J
Front Microbiol; 2020; 11():1840. PubMed ID: 32849438
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Oral dysbiosis and its linkage with SARS-CoV-2 infection.
Gupta A; Bhanushali S; Sanap A; Shekatkar M; Kharat A; Raut C; Bhonde R; Shouche Y; Kheur S; Sharma A
Microbiol Res; 2022 Aug; 261():127055. PubMed ID: 35597076
[TBL] [Abstract][Full Text] [Related]
4. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.
Hoque MN; Akter S; Mishu ID; Islam MR; Rahman MS; Akhter M; Islam I; Hasan MM; Rahaman MM; Sultana M; Islam T; Hossain MA
Microb Pathog; 2021 Jul; 156():104941. PubMed ID: 33962007
[TBL] [Abstract][Full Text] [Related]
5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
6. The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19.
Andrade BGN; Cuadrat RRC; Tonetti FR; Kitazawa H; Villena J
Biosci Microbiota Food Health; 2022; 41(3):94-102. PubMed ID: 35846832
[TBL] [Abstract][Full Text] [Related]
7. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
[TBL] [Abstract][Full Text] [Related]
8. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
10. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity and COVID-19 - The microbiotal connection.
Katz-Agranov N; Zandman-Goddard G
Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections.
Naqvi AR; Schwartz J; Brandini DA; Schaller S; Hussein H; Valverde A; Naqvi RA; Shukla D
Int Rev Immunol; 2022; 41(4):423-437. PubMed ID: 34525891
[TBL] [Abstract][Full Text] [Related]
16. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
Xiang Z; Koo H; Chen Q; Zhou X; Liu Y; Simon-Soro A
J Oral Microbiol; 2020 Nov; 13(1):1853451. PubMed ID: 33312449
[TBL] [Abstract][Full Text] [Related]
17. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Leaving no stone unturned in light of the COVID-19 faecal-oral hypothesis? A water, sanitation and hygiene (WASH) perspective targeting low-income countries.
Gwenzi W
Sci Total Environ; 2021 Jan; 753():141751. PubMed ID: 32911161
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types.
Gupta A; Karyakarte R; Joshi S; Das R; Jani K; Shouche Y; Sharma A
Microbes Infect; 2022 Feb; 24(1):104880. PubMed ID: 34425246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
